Clinical Trial Update: Tolerability of Enteral NAC in Infants [Phase 1]

View source ↗

Summary

A Phase 1 trial is evaluating the tolerability of enteral N-acetylcysteine in infants with biliary atresia; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Atresia

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Sanjiv Harpavat | Conditions: Biliary Atresia | Phase 1 | Status: NOT_YET_RECRUITING